Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDOX: Duration of Long-Term Oxygen Therapy and Mortality
2016-000441-32Phase 4Completed
- Sponsor
- Region Blekinge
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxygen in chronic respiratory failure (2 arms), sponsored by Region Blekinge. Primary endpoint: Composite of all-cause death or first hospitalization at 1 year. Started Mar 2016; status: completed.
02
Drugs
oxygen
03
Conditions
chronic respiratory failure
Beyond the preview
Go deeper on 2016-000441-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000441-32.